Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Liabilities and Shareholders Equity (2016 - 2025)

AtriCure (ATRC) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $654.2 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 7.36% to $654.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 billion through Dec 2025, up 3.18% year-over-year, with the annual reading at $654.2 million for FY2025, 7.36% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $654.2 million at AtriCure, up from $635.4 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $701.1 million in Q2 2021, with the low at $581.9 million in Q3 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $613.2 million, with a median of $604.6 million recorded in 2023.
  • The sharpest move saw Liabilities and Shareholders Equity surged 32.62% in 2021, then fell 16.42% in 2022.
  • Over 5 years, Liabilities and Shareholders Equity stood at $615.3 million in 2021, then fell by 4.85% to $585.4 million in 2022, then grew by 4.87% to $613.9 million in 2023, then decreased by 0.75% to $609.3 million in 2024, then grew by 7.36% to $654.2 million in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $654.2 million, $635.4 million, and $608.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.